ANTARES PHARMA INC - COM (ATRS)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
82,142,607
Share change
-1,351,847
Total reported value
$358,169,821
Put/Call ratio
310%
Price per share
$4.36
Number of holders
173
Value change
-$4,684,046
Number of buys
76
Number of sells
69

Institutional Holders of ANTARES PHARMA INC - COM (ATRS) as of Q2 2021

As of 30 Jun 2021, ANTARES PHARMA INC - COM (ATRS) was held by 173 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 82,142,607 shares. The largest 10 holders included BlackRock Inc., Rubric Capital Management LP, VANGUARD GROUP INC, Sargent Investment Group, LLC, STATE STREET CORP, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, Nuveen Asset Management, LLC, FIRST WILSHIRE SECURITIES MANAGEMENT INC, and AMUNDI. This page lists 173 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.